☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Bio-Thera Solutions
Bio-Thera Solutions Expands its Partnership with Pharmapark for BAT2306 (Biosimilar, Cosentyx) Across Russia and Other Countries
August 20, 2024
Bio-Thera Solutions Reports the Initiation of Combined P-I/P-III Study of BAT3306 (Biosimilar, Keytruda)
July 25, 2024
Bio-Thera Solutions and SteinCares Collaborate for Marketing Biosimilars Across LATAM
March 19, 2024
PharmaShots Weekly Snapshots (October 09–13, 2023) _
October 14, 2023
Bio-Thera Solutions Receives the US FDA’s Approval for Tofidence (biosimilar, tocilizumab)
October 9, 2023
Bio-Thera Solutions Demonstrated High Similarity Between BAT1706, a proposed biosimilar of bevacizumab and Reference Bevacizumab
July 27, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.